Yoga Therapy for Ovarian Cancer Prehabilitation

This study is testing a comprehensive yoga therapy (CYT) program for women with ovarian, fallopian tube, or primary peritoneal cancer who are about to start chemotherapy and then have surgery. The program includes two weekly visits with a yoga therapist for dietary counseling, yoga movements, breathing exercises, mind practices, and behavioral support. Researchers want to see if this program is practical to offer (feasibility) and how it affects patients' quality of life, physical fitness, and surgical outcomes. You might be able to join if you are a woman aged 18 or older with stage III-IV ovarian cancer, can read English, and have internet access. The study aims to enroll 40 participants, but its current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 40 women. It compares a comprehensive yoga therapy program with usual supportive care.
What's involved
Participants in the yoga therapy group will have two visits per week with a yoga therapist while receiving chemotherapy. The study will last for an average of one year.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed through study completion, which is an average of one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06545604

Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer

Recruiting
NAAges 18+InterventionalSupportive care
M.D. Anderson Cancer Center
~55 participants
Updated 2026-07-29 on ClinicalTrials.gov
What's tested:Yoga Therapy for Nutritional, Physical, and Psychosocial PrehabilitationUsual care supportive services including nutrition counseling per usual care

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To assess the feasibility of a CYT prehabilitation program in women with ovarian cancer scheduled to receive NACT and IDS.
Measured over Through study completion; an average of 1 year
Ovarian Cancer
1 sites across 1 states
Texas1
  • Lois Ramondetta, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

  • To assess the feasibility of a CYT prehabilitation program in women with ovarian cancer scheduled to receive NACT and IDS.Through study completion; an average of 1 year